Burrows Scott L

Insider CIK 1853327 · SYRE Chief Financial Officer · ARQT Chief Financial Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-10-01	2026-10-02	7,500	—	$0	312,357	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-10-01	2026-10-02	229	$93.57	$21.4K	79,762	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-10-01	2026-10-02	3,071	$92.95	$285.4K	79,991	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-10-01	2026-10-02	2,100	$91.92	$193.0K	83,062	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-10-01	2026-10-02	1,500	$90.27	$135.4K	85,162	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-10-01	2026-10-02	600	$89.07	$53.4K	86,662	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-10-01	2026-10-02	7,500	$14.50	$108.8K	87,262	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-09-30	2026-10-02	17,500	—	$0	319,857	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-09-30	2026-10-02	17,500	$89.89	$1.57M	79,762	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-09-30	2026-10-02	17,500	$14.50	$253.8K	97,262	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-09-02	2026-09-03	18,232	$89.35	$1.63M	79,762	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-09-02	2026-09-03	18,232	$89.35	$1.63M	79,762	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-09-01	2026-09-03	7,500	—	$0	337,357	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-09-01	2026-09-03	7,500	$14.50	$108.8K	105,494	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-09-01	2026-09-03	4,384	$87.11	$381.9K	100,210	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-09-01	2026-09-03	900	$86.25	$77.6K	104,594	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-09-01	2026-09-03	2,016	$88.03	$177.5K	98,194	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-09-01	2026-09-03	200	$89.04	$17.8K	97,994	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-09-01	2026-09-03	7,500	—	$0	337,357	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-09-01	2026-09-03	200	$89.04	$17.8K	97,994	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-09-01	2026-09-03	2,016	$88.03	$177.5K	98,194	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-09-01	2026-09-03	4,384	$87.11	$381.9K	100,210	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-09-01	2026-09-03	900	$86.25	$77.6K	104,594	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-09-01	2026-09-03	7,500	$14.50	$108.8K	105,494	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-08-03	2026-08-05	7,500	—	$0	344,857	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-08-03	2026-08-05	100	$97.10	$9.7K	97,994	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-08-03	2026-08-05	7,500	$14.50	$108.8K	105,494	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-08-03	2026-08-05	5,100	$95.21	$485.6K	100,394	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-08-03	2026-08-05	2,300	$96.30	$221.5K	98,094	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-08-03	2026-08-05	7,500	—	$0	344,857	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-08-03	2026-08-05	100	$97.10	$9.7K	97,994	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-08-03	2026-08-05	2,300	$96.30	$221.5K	98,094	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-08-03	2026-08-05	5,100	$95.21	$485.6K	100,394	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-08-03	2026-08-05	7,500	$14.50	$108.8K	105,494	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-07-01	2026-07-02	7,500	—	$0	352,357	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-07-01	2026-07-02	7,500	$14.50	$108.8K	105,494	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-07-01	2026-07-02	1,725	$88.37	$152.4K	97,994	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-07-01	2026-07-02	5,775	$87.55	$505.6K	99,719	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-06-25	2026-06-26	15,000	—	$0	359,857	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-06-25	2026-06-26	15,000	$14.50	$217.5K	112,994	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-06-25	2026-06-26	10,000	$87.14	$871.4K	97,994	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-06-25	2026-06-26	5,000	$87.12	$435.6K	107,994	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-06-01	2026-06-03	7,500	—	$0	374,857	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-06-01	2026-06-03	7,500	$14.50	$108.8K	105,494	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-06-01	2026-06-03	1,801	$69.75	$125.6K	103,693	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-06-01	2026-06-03	2,599	$70.77	$183.9K	101,094	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-06-01	2026-06-03	3,100	$72.06	$223.4K	97,994	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-05-01	2026-05-01	12,500	—	$0	382,357	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-05-01	2026-05-01	12,500	$14.50	$181.3K	110,494	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-05-01	2026-05-01	12,500	$71.37	$892.1K	97,994	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-04-01	2026-04-03	7,500	—	$0	394,857	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-04-01	2026-04-03	1,300	$49.98	$65.0K	97,994	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-04-01	2026-04-03	6,200	$49.21	$305.1K	99,294	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-04-01	2026-04-03	7,500	$14.50	$108.8K	105,494	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise deriv	2026-03-03	2026-03-03	2,500	—	$0	402,357	SEC↗
SYRE Spyre Therapeutics, Inc.	M Exercise	2026-03-03	2026-03-03	2,500	$14.50	$36.3K	100,494	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-03-03	2026-03-03	2,300	$40.56	$93.3K	98,194	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2026-03-03	2026-03-03	200	$41.66	$8.3K	97,994	SEC↗
SYRE Spyre Therapeutics, Inc.	A Award deriv	2026-01-09	2026-01-13	140,000	—	$0	140,000	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2025-09-02	2025-09-03	18,428	$16.26	$299.6K	97,994	SEC↗
SYRE Spyre Therapeutics, Inc.	A Award deriv	2025-01-15	2025-01-17	95,500	—	$0	95,500	SEC↗
SYRE Spyre Therapeutics, Inc.	S Sale	2024-09-03	2024-09-05	18,531	$28.17	$522.0K	116,422	SEC↗
SYRE Spyre Therapeutics, Inc.	A Award deriv	2024-02-01	2024-02-02	70,000	—	$0	70,000	SEC↗
SYRE Spyre Therapeutics, Inc.	A Award	2023-12-22	2023-12-22	134,953	—	$0	134,953	SEC↗
AGLE Aeglea BioTherapeutics, In	A Award deriv	2023-09-01	2023-09-05	10,121,441	—	$0	10,121,441	SEC↗
ARQT Arcutis Biotherapeutics, I	S Sale	2023-03-06	2023-03-08	291	$15.26	$4.4K	59,115	SEC↗
ARQT Arcutis Biotherapeutics, I	A Award deriv	2023-03-02	2023-03-06	55,800	—	$0	55,800	SEC↗
ARQT Arcutis Biotherapeutics, I	S Sale	2023-03-02	2023-03-02	18	$16.52	$297	38,406	SEC↗
ARQT Arcutis Biotherapeutics, I	S Sale	2023-03-02	2023-03-02	1,416	$15.82	$22.4K	38,424	SEC↗
ARQT Arcutis Biotherapeutics, I	A Award	2023-03-02	2023-03-06	21,000	—	$0	59,406	SEC↗
ARQT Arcutis Biotherapeutics, I	S Sale	2023-02-28	2023-03-02	416	$16.17	$6.7K	39,840	SEC↗
ARQT Arcutis Biotherapeutics, I	M Exercise deriv	2022-09-16	2022-09-20	5,000	—	$0	37,277	SEC↗
ARQT Arcutis Biotherapeutics, I	M Exercise	2022-09-16	2022-09-20	5,000	$1.68	$8.4K	40,256	SEC↗
ARQT Arcutis Biotherapeutics, I	S Sale	2022-03-07	2022-03-07	10	$16.44	$164	35,256	SEC↗
ARQT Arcutis Biotherapeutics, I	S Sale	2022-03-04	2022-03-07	293	$16.86	$4.9K	35,266	SEC↗
ARQT Arcutis Biotherapeutics, I	A Award deriv	2022-03-03	2022-03-07	35,300	—	$0	35,300	SEC↗
ARQT Arcutis Biotherapeutics, I	A Award	2022-03-03	2022-03-07	13,300	—	$0	35,559	SEC↗
ARQT Arcutis Biotherapeutics, I	S Sale	2022-03-01	2022-03-03	420	$17.75	$7.5K	22,259	SEC↗
ARQT Arcutis Biotherapeutics, I	A Award deriv	2021-12-30	2022-01-04	55,704	—	$0	55,704	SEC↗
ARQT Arcutis Biotherapeutics, I	S Sale	2021-12-27	2021-12-28	12,560	$20.07	$252.1K	22,679	SEC↗
ARQT Arcutis Biotherapeutics, I	A Award deriv	2021-04-01	2021-04-05	23,000	—	$0	23,000	SEC↗